Related Experiment Video
Updated: Jun 3, 2026
08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
[Screening of tuberculosis specific antibody binding peptides]
Huan-sen Yang1, Zhong-yi Hu, Zhong-hua Liu
1College of Basic Medicine and Life Science, Soochow University, Suzhou 215123, China.
Summary
Researchers screened tuberculosis-specific antibody binding peptides using phage display technology. These identified peptides show specific binding to tuberculosis IgG, forming a basis for developing new tuberculosis serological detection reagents.
Area of Science:
- Molecular Biology
- Immunology
- Biotechnology
Context:
- Tuberculosis (TB) diagnosis relies on sensitive and specific methods.
- Phage display technology offers a powerful tool for identifying specific biomolecular interactions.
- Developing novel serological detection reagents for TB is crucial for early diagnosis and management.
Purpose:
- To screen for specific antibody-binding peptides targeting tuberculosis using phage-displayed random peptide libraries.
- To identify peptides that specifically bind to immunoglobulin G (IgG) from tuberculosis patient serum.
- To lay the groundwork for developing new serological diagnostic reagents for tuberculosis.
Summary:
- Purified IgG from tuberculosis serum was used to screen a phage-displayed peptide library (Ph.D.-7).
- After three rounds of biopanning and counter-selection with healthy individuals' IgG, phage clone H12 demonstrated high affinity and specificity for tuberculosis IgG.
- Indirect enzyme-linked immunosorbent assay (ELISA) confirmed that phage clone H12 significantly differentiated between tuberculosis patients and healthy individuals, with a P < 0.0001.
Impact:
- Successfully identified specific antibody-binding peptides for tuberculosis.
- Demonstrated the potential of these peptides for developing novel, peptide-based serological diagnostic tools for tuberculosis.
- Provides a foundation for advancing TB diagnostics through innovative biotechnological approaches.
